# Pfizer expands Rocky Mount injectable facility to $190 million

Pfizer is continuing construction at its Rocky Mount, North Carolina site, increasing the scope of its sterile injectable manufacturing facility expansion from $159 million to $190 million, adding a 65,000-square-foot adjacent facility. No new jobs are expected.

- Type: Expansion
- Announced: 2017-02-21
- Where: Rocky Mount, North Carolina, United States
- Value: $190.0M
- Jobs: 0
- Status: under construction
- Products: sterile injectable pharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Pfizer](https://endata.com/companies/892.md)

## Sources

- [biospace.com](https://www.biospace.com/pfizer-continues-190-million-expansion-plans-in-north-carolina), 2017-02-21: "The original plan for the new sterile injectable manufacturing facility was to create new capacity to shift product volumes from some of our aging lines in the existing sterile manufacturing facility to the new facility."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.